CD14 and lymphoma: Khalifa et al. [52] found that lymphomas with an increased number of CD14+ monocytes and with loss of human leukocyte antigen-DR (HLA-DR) expression were more aggressive and more frequently associated with refractory disease or relapse to treatment.